Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.650
+0.060 (3.77%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Evaxion Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-10.57-22.13-23.17-24.53-15.02
Upgrade
Depreciation & Amortization
0.610.620.570.340.11
Upgrade
Asset Writedown & Restructuring Costs
--0.09--
Upgrade
Stock-Based Compensation
0.360.480.941.383.41
Upgrade
Other Operating Activities
-3.861.78-1.33-0.36-1.15
Upgrade
Change in Accounts Receivable
0.371.11-1.491.86-2.5
Upgrade
Change in Accounts Payable
0.450.5-0.6-0.651.8
Upgrade
Change in Other Net Operating Assets
-0.3-0.05-0.790.020.92
Upgrade
Operating Cash Flow
-12.94-17.69-25.77-21.93-12.44
Upgrade
Capital Expenditures
--0.09-0.29-1.3-0.15
Upgrade
Sale (Purchase) of Intangibles
----0.06-0.04
Upgrade
Other Investing Activities
-0-0.010.020.03-0.21
Upgrade
Investing Cash Flow
-0-0.09-0.27-1.33-0.39
Upgrade
Long-Term Debt Issued
0.060.077.85--
Upgrade
Long-Term Debt Repaid
-1.14-0.7-0.42-0.29-0.07
Upgrade
Net Debt Issued (Repaid)
-1.08-0.637.43-0.29-0.07
Upgrade
Issuance of Common Stock
16.559.170.4353.859.02
Upgrade
Other Financing Activities
-2.342.16--3.76-0.13
Upgrade
Financing Cash Flow
13.1310.697.8549.818.82
Upgrade
Foreign Exchange Rate Adjustments
0.18-0.51-0.79-0.210.29
Upgrade
Net Cash Flow
0.37-7.6-18.9826.33-3.73
Upgrade
Free Cash Flow
-12.94-17.78-26.07-23.23-12.59
Upgrade
Free Cash Flow Margin
-386.96%-24353.42%---
Upgrade
Free Cash Flow Per Share
-12.06-32.52-55.13-59.59-40.77
Upgrade
Cash Interest Paid
0.060.070.170.030.03
Upgrade
Cash Income Tax Paid
--1.6-0.75-0.85-0.81
Upgrade
Levered Free Cash Flow
-11.59-9.12-16.89-14.33-7.54
Upgrade
Unlevered Free Cash Flow
-10.99-8.56-16.39-14.23-7.52
Upgrade
Change in Net Working Capital
2.75-4.311.82-1.550.5
Upgrade
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q